Composite packaging has become the mainstream packaging form for oral medicines, including tablets, capsules, granules and oral liquids, thanks to its excellent barrier performance, lightweight structure and cost advantages. As the most common primary pharmaceutical packaging, it directly contacts oral drugs and protects their efficacy, purity and shelf-life stability. With global pharmaceutical safety supervision becoming increasingly rigorous, traditional packaging adhesives can no longer meet high-end pharmaceutical production standards. Currently, solvent-free polyurethane (PU) lamination adhesives, which have passed authoritative medical-grade certification, are widely popularized in oral drug composite packaging, comprehensively upgrading the safety level of pharmaceutical packaging.
Oral medicine packaging has extremely strict access thresholds, requiring zero solvent residue, zero harmful migration and high chemical stability. Traditional solvent-based laminating adhesives are widely criticized for residual volatile organic compounds. During packaging lamination and long-term drug storage, residual solvents may penetrate the packaging layer and contaminate oral medicines. They can react with drug active ingredients, causing efficacy degradation, flavor distortion and even potential health risks for patients. Moreover, unstable bonding of traditional adhesives easily leads to packaging delamination and air leakage, resulting in drug moisture absorption and oxidation.
Certified with professional medical-grade qualifications, solvent-free PU lamination adhesives completely eliminate the safety hazards of traditional adhesive products. Adopting a pure 100% solid-content formula without any volatile solvents or toxic additives, the material undergoes sufficient cross-linking curing to form a dense and inert adhesive layer. It achieves tight and stable lamination bonding for multi-layer composite substrates such as PET, AL and PE, forming an airtight protective structure that effectively isolates oxygen, moisture and external pollutants.
The core competitiveness of the product lies in its authoritative medical compliance capabilities. The adhesive has successfully passed multiple global medical-grade certifications, including USP Class VI medical material testing, EU pharmaceutical packaging safety specifications, and China’s YBB pharmaceutical packaging standards and GB 4806 food-contact safety regulations. Professional tests verify that the material features ultra-low extractable and leachable substances, with no harmful chemical precipitation during long-term contact with oral drugs.
In addition to superior safety performance, the certified adhesive delivers stable mechanical and barrier properties suitable for oral drug circulation. It maintains intact lamination structure and stable bonding strength under normal-temperature storage, humid logistics and conventional disinfection environments. It effectively prevents packaging bubbling, delamination and leakage, stably locks drug purity, and extends the valid period of oral medicines, adapting to the full-cycle storage and transportation needs of various oral pharmaceutical products.
Industry insiders stated that medical-grade certification is the core pass for pharmaceutical packaging materials. The large-scale application of certified solvent-free PU lamination adhesives has standardized the production process of oral drug composite packaging, solved the long-standing hidden safety hazards of traditional packaging, and realized comprehensive upgrading of pharmaceutical packaging safety, green performance and stability.
Driven by the high-quality development of the pharmaceutical industry, medical-grade and eco-friendly packaging materials will become the industry mandatory standard. Solvent-free PU lamination adhesive technology will continue to be widely applied in oral drug packaging scenarios, providing solid, certified safety guarantees for global oral pharmaceutical production and protecting public medication safety.